Mounjaro injection (tirzepatide)

MOUNJARO INJECTION (TIRZEPATIDE) is a once-weekly injectable medication used to manage Type 2 Diabetes Mellitus and support weight loss. It combines dual GIP and GLP-1 receptor agonist action to improve blood sugar levels, increase insulin sensitivity, and reduce appetite. MOUNJARO helps lower HbA1c effectively while promoting healthy metabolic function. It’s ideal for patients needing advanced glycemic control and body weight reduction. MOUNJARO (TIRZEPATIDE) is a cutting-edge therapy for modern diabetes and obesity care.